Valneva SE - VALN

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$45.83M
QoQ value delta ($000)
-$18.5M (-28.76%)
Implied price effect (QoQ)
-27.71%
Shares
Total shares
5,196,705
QoQ shares delta
-76,893 (-1.46%)
Total shares held by funds (by quarter)

Market chart (VALN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Novo Holdings A/S 20,330 2,305,000 1.58%
Frazier Life Sciences Management, L.P. 20,212 2,291,666 0.54%
GENERAL AMERICAN INVESTORS CO INC 3,125 354,361 0.18%
WELLS FARGO & COMPANY/MN 1,088 123,463 0.0%
MORGAN STANLEY 379 42,981 0.0%
IRONWOOD INVESTMENT MANAGEMENT LLC 221 25,135 0.09%
CITADEL ADVISORS LLC 207 23,494 0.0%
XTX Topco Ltd 93 10,634 0.0%
JPMORGAN CHASE & CO 82 9,396 0.0%
China Universal Asset Management Co., Ltd. 44 5,000 0.0%
GAMMA Investing LLC 16 1,857 0.0%
RHUMBLINE ADVISERS 15 1,763 0.0%
OSAIC HOLDINGS, INC. 13 1,555 0.0%
UBS Group AG 1 203 0.0%
Clearstead Advisors, LLC 0 48 0.0%
Allworth Financial LP 0 7 0.0%
EverSource Wealth Advisors, LLC 0 98 0.0%
Activest Wealth Management 0 1 0.0%
Smartleaf Asset Management LLC 0 43 0.0%